AzTrials
AzTrials

Pelvic Organ ProlapseNCT02925585

Vaginal Tactile Imaging for Pelvic Floor Prolapse

An observational study of Pelvic Organ Prolapse, run by Artann Laboratories at 5 sites in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators will analyze biomechanical transformation of pelvic floor tissues and support structures under affected pelvic floor conditions and repaired states after the surgery. Read more about this study

Who is it for?
Ages 21 years and older, women only
Conditions the study is for
Pelvic Organ Prolapse
What is being tested?
Pre/post imaging
How many people
119 participants
Where
5 sitesUnited States
Study dates
Sep 2016to Dec 2018
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients scheduled for pelvic floor surgery

Who may be able to join

  • Subject is female of 21 years or older, and
  • No prior pelvic floor surgery, and
  • One of the following:
  • Normal pelvic floor conditions, or POP Stage I affecting one or more vaginal compartment, or POP Stage II affecting one or more vaginal compartment, or POP Stage III affecting one or more vaginal compartment, or POP Stage IV affecting one or more vaginal compartment

Who cannot join

  • Active skin infection or ulceration within the vagina
  • Presence of a vaginal septum;
  • Active cancer of the colon, rectum wall, cervix, vaginal, uterus or bladder;
  • Ongoing radiation therapy for pelvic cancer;
  • Impacted stool;
  • Significant pre-existing pelvic pain including levator ani syndrome, severe vaginismus or vulvadynia;
Show all 9Show fewer
  • Severe hemorrhoids;
  • Significant circulatory or cardiac conditions that could cause excessive risk from the examination as determined by attending physician;
  • Current pregnancy.

Trial locations and contacts

5 sites in 1 country.

5 sites in 1 country

United States5 sites
  • The Institute for Female Pelvic Medicine and Reconstructive Surgery

    Allentown, Pennsylvania, 18103

  • Inova Health System Foundation

    Falls Church, Virginia, 22042

  • Eastern Virginia Medical School

    Norfolk, Virginia, 23501

  • Princeton Urogynecology PU

    Princeton, New Jersey, 08540

  • The Pelvic Floor Institute

    Tampa, Florida, 33606

Other trials in United States

About this study

Official title: Vaginal Tactile Imaging in Assessment of Pelvic Floor Conditions

The investigators will analyze biomechanical transformation of pelvic floor tissues and support structures under affected pelvic floor conditions and repaired states after the surgery.

Being tested
Pre/post imaging
Medical subject headings
Pelvic Organ Prolapse

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Pre/post imagingOther

Study groups in NCT02925585
Study groupRoleWhat they receive
Pre/post pelvic floor surgery imagingNot described
Receives: Other: Pre/post imaging

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Tissue elasticity change after the surgery measured as a gradient in tactile image. Unit of measure: mmHg/mm

    Tissue elasticity is measured for entire anterior and posterior compartments

    Measured: pre-surgery and post-surgery (4-6 months after surgery) measurements

  2. Pelvic floor muscle strength change after the surgery measured as a pressure dynamic feedback during muscle contractions. Unit of measure: mmHg

    Muscle strength is measured during voluntary and involuntary muscle contractions, involuntary relaxation and Valsalva maneuver.

    Measured: pre-surgery and post-surgery (4-6 months after surgery) measurements

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Oct 2016 (estimated)
  2. Study startSep 2016
  3. Primary completionDec 2018
  4. Study completionDec 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
119 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02925585
Sponsor's protocol ID
VTI09
Other IDs
SB1AG034714
Status last verified
Mar 2019
First submitted
3 Oct 2016
Last updated
21 Mar 2019
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes: Scientific Publications of the study results

Questions about this trial

What is this clinical trial studying?

An observational study of Pelvic Organ Prolapse, run by Artann Laboratories at 5 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Mar 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Tissue elasticity change after the surgery measured as a gradient in tactile image. Unit of measure: mmHg/mm (time frame: pre-surgery and post-surgery (4-6 months after surgery) measurements). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Mar 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in